European Equities Traded in the US as ADRs Tick Higher in Wednesday Trading

MT Newswires Live
11/12

European equities traded in the US as American depositary receipts edged up late Wednesday morning with the S&P Europe Select ADR Index rising 0.1% to 1,896.24, erasing earlier declines.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and accommodations-booking company trivago (TRVG), which climbed 26% and 2.6%, respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and semiconductor company Sequans Communications (SQNS), which increased 2.5% each.

The decliners from continental Europe were led by brewing company Anheuser-Busch InBev (BUD) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which fell 2.9% and 1.8%, respectively. They were followed by lender Banco Santander (SAN) and biopharmaceutical company Grifols (GRFS), which were down 1.2% and 0.5%, respectively.

The gainers from the UK were led by biopharmaceutical companies NuCana (NCNA) and Akari Therapeutics (AKTX), which rose 2.7% and 2.1%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and oil and gas company BP (BP), which were up 1.8% and 1.3%, respectively.

The decliners from the UK and Ireland were led by biotech firms Autolus Therapeutics (AUTL) and Trinity Biotech (TRIB), which dropped 7.2% and 5%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and pharmaceutical company GSK (GSK), which decreased 2.9% and 2.6%, respectively.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10